Overview

Investing in and prioritizing research to study the effectiveness of Alzheimer’s disease clinical study recruitment strategies, support program evaluation and disseminate best practices is critical to developing an applied science of recruitment. Public and private research funding agencies, academic institutions and researchers globally have an important role in evaluating the effectiveness of their own strategies, making transparent their research methodology, and sharing results broadly and promptly. Globally, agencies and national advocacy organizations can help develop, collect and widely disseminate research-based best practices.

This AAIC event comes at an important time in the ongoing partnership between scientists and the public to find more effective ways to prevent, diagnose and treat Alzheimer’s disease and related dementias (AD/ADRD). There is now an unprecedented opportunity to build on scientific knowledge and to accelerate and expand the research effort around recruitment strategies, and it is incumbent upon all of us to leverage our different missions, interests and resources to meet this critical need. The goal of this preconference is to provide us a global perspective that will help build a strong scientific foundation for the science of recruitment around AD/ADRD clinical trials.

Through this AAIC event, we will provide a global forum to make progress toward this important goal. We aim to identify opportunities to accelerate and expand existing efforts and discuss novel approaches, including building new collaborations and partnerships. While we can support and incentivize improved recruitment in several ways, successfully developing an applied science of recruitment requires involvement and contributions from a diverse range of stakeholders, including those involved in funding, regulating, guiding or using outcomes from research. This might include:

• Focusing on funding opportunity announcements or procedures.
• Shaping application submission and review requirements.
• Working directly with investigators.
• Collecting and disseminating evidence-based strategies in a central location.
• Supporting evaluation efforts and compilation of the evidence base.
• Providing a global voice to communicate the importance of developing an applied science of recruitment.

Objectives

Specific objectives of the meeting include:

1. Discuss global recruitment strategies and evidence-based practices supporting the science of recruitment.
2. Identify challenges, set priority areas and goals to build on existing knowledge and address gaps, with a focus on enhancing participant diversity.
3. Identify opportunities to accelerate and expand existing efforts to support the applied science of recruitment, including building new collaborations and partnerships to increase the diversity of participants.
4. Ensure that recruitment strategies support ethical and inclusive approaches that address the broad spectrum of people with dementia.
5. Discuss potential incentives to encourage the reporting of best practices and lessons learned as they emerge.

Agenda

View the agenda.

Target Audience

This session is open to international experts and practitioners invested or interested in participant recruitment to Alzheimer’s Disease and Related Dementias (AD/ADRD) clinical trials.